HHS grants a research award to California-based company to develop and test a new model that could contribute to more rapid and accurate flu surveillance.
The effort to curtail the impact of influenza just got a shot in the arm with a research award from a division of the U.S. Department of Health & Human Services (HHS) to a company that's testing a machine learning model to improve flu forecasts based on data gathered from wearable devices.
Current forecasting initiatives lag behind actual incidence because of reporting delays, says Ernesto Ramirez, PhD, senior data scientist for Evidation, a San Mateo, California-based company. The health and measurement company, which uses data to better understand the connection between everyday behaviors and health, hopes its work will accelerate the reporting process, says Ramirez, leading to more accurate, timely forecasts, plus earlier intervention and treatment.
Evidation received the research award, worth up to $749,000, depending on the final scope of work, from the Division of Research, Innovation, and Ventures (DRIVe) which operates under the HHS Biomedical Advanced Research and Development Authority (BARDA).
Challenges With Current Flu Forecasting
Current forecasting models rely upon data gathered from physician's offices, urgent care centers, hospitals, and other sites, Ramirez explains. These providers then report to public health agencies, which then relay data to the Centers for Disease Control.
The process not only creates a delay between real time flu incidence and reported data, says Ramirez, it also omits those who have the flu, but don't seek medical intervention. One study, published June 2018 in Vaccine, estimates that number to be 21.6 million people.
Wearable Devices and Machine Learning Change Forecasting Dynamics
Evidation's model, which is still in development, will use activity, sleep, and heart rate data, for example, gathered from commercially available wearable devices worn by study participants, Ramirez says. In addition, the flu diagnosis will be validated via a specimen, such as a nasal swab from a home testing kit. Information also will be gleaned from surveys administered to participants.
Evidation will use high frequency sensor data from the wearable devices to understand the characteristics that are indicative of a flu diagnosis, he says.
"We are applying some interesting data science principles all the way across data ingestion, to data cleaning, to machine learning to better understand these classification issues," Ramirez says. Thanks to the flu validation data, the models emerging from this analysis will also distinguish between respiratory virus infections and influenza.
"We will then hopefully move into what we consider a forecasting problem, which directly aligns with improving surveillance, and sometime in the future, helping to prevent a flu spread," says Ramirez.
The study will begin during the fall 2019 flu season, and work will continue through 2020.
Why Better Forecasting Matters
Influenza has a tremendous impact on public health and healthcare costs. Earlier diagnosis and treatment can help reduce cost and diminish the impact of the disease, says Ramirez. According to the article in Vaccine:
- The estimated average annual total economic burden of influenza to the healthcare system and society was $11.2 billion
- Direct medical costs were estimated to be $3.2 billion
- Indirect costs were estimated to be $8.0 billion
These costs included:
- 21.6 million patients who were "medically unattended"
- 3.7 million office-based outpatient visits
- .65 million emergency department visits
- 247,000 hospitalizations
- 36,300 deaths
- 20.1 million days of lost productivity lost
The award is part of HHS' Early Notification to Act Control and Treat (ENACT) program, offered through DRIVe, to invest in disruptive innovations that will protect Americans against health security threats.
Mandy Roth is the innovations editor at HealthLeaders.